119 related articles for article (PubMed ID: 3937178)
1. Changes in brain catecholamine levels following DL-dopa are not potentiated by deuterium substitution.
Dewar KM; Dyck LE; Durden DA; Boulton AA
Prog Neuropsychopharmacol Biol Psychiatry; 1985; 9(5-6):675-80. PubMed ID: 3937178
[TBL] [Abstract][Full Text] [Related]
2. The effect of l-DOPA and benserazide on the amount of dopamine in the corpus striatum of X-irradiated rats.
Stepanović SR; Nikolić J
Experientia; 1983 Sep; 39(9):1050-1. PubMed ID: 6411487
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometric measurement of catecholamine turnover in rat hypothalamus after long-term L-dopa infusion.
Freed CR; Murphy RC
J Pharmacol Exp Ther; 1978 Jun; 205(3):702-9. PubMed ID: 660538
[TBL] [Abstract][Full Text] [Related]
4. Selective reserpine-resistant accumulation of catecholamines in central dopamine neurones after DOPA administration.
Lidbrink P; Jonsson G; Fuxe K
Brain Res; 1974 Mar; 67(3):439-56. PubMed ID: 4470434
[No Abstract] [Full Text] [Related]
5. Effects of different monoamine oxidase inhibitors on the metabolism of L-dopa in the rat brain.
Nguyen TB; Angers M
Biochem Pharmacol; 1987 May; 36(10):1731-5. PubMed ID: 3109430
[TBL] [Abstract][Full Text] [Related]
6. The role of the adrenergic system in the action of L-DOPA on brain serotonin.
Algeri S; Cerletti C
Adv Biochem Psychopharmacol; 1974; 10():257-9. PubMed ID: 4846542
[No Abstract] [Full Text] [Related]
7. BIA 3-202, a novel catechol-O-methyltransferase inhibitor, enhances the availability of L-DOPA to the brain and reduces its O-methylation.
Parada A; Loureiro AI; Vieira-Coelho MA; Hainzl D; Soares-da-Silva P
Eur J Pharmacol; 2001 May; 420(1):27-32. PubMed ID: 11412836
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of benserazide on catecholamine concentrations in the rat pineal, cerebral cortex and hypothalamus.
Ho AK; Smith JA
Biochem Pharmacol; 1983 Dec; 32(23):3605-9. PubMed ID: 6651878
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute and chronic phenelzine on regional monoamine metabolism in rats and its potentiation by deuterium substitution.
Juorio AV; Greenshaw AJ; Boulton AA
Naunyn Schmiedebergs Arch Pharmacol; 1986 Jul; 333(3):240-5. PubMed ID: 2429193
[TBL] [Abstract][Full Text] [Related]
10. Selective lesions of central catecholamine pathways: application in functional studies.
Ungerstedt U
Neurosci Res (N Y); 1973; 5(0):73-96. PubMed ID: 4600813
[No Abstract] [Full Text] [Related]
11. Effect of L-DOPA on S-adenosylmethionine levels and norepinephrine metabolism in rat brain.
Wurtman RJ
Adv Biochem Psychopharmacol; 1972; 6():241-6. PubMed ID: 5055596
[No Abstract] [Full Text] [Related]
12. Chemical lonization mass spectrometric measurement of alpha-methyldopa and s-dopa metabolites in rat brain regions.
Freed CR; Weinkam RJ; Melmon KL; Castagnoli N
Anal Biochem; 1977 Apr; 78(2):319-32. PubMed ID: 851208
[No Abstract] [Full Text] [Related]
13. [Interactions of cerebral serotonin and catecholamines].
Watanabe Y
Nihon Yakurigaku Zasshi; 1983 May; 81(5):365-83. PubMed ID: 6195056
[TBL] [Abstract][Full Text] [Related]
14. Dopamine, noradrenaline and 5-hydroxy-trytamine in relation to motor activity, fighting and mounting behaviour. II. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602 and parachlorophenylalanine.
Benkert O; Renz A; Matussek N
Neuropharmacology; 1973 Mar; 12(3):187-93. PubMed ID: 4266876
[No Abstract] [Full Text] [Related]
15. The effect of benserazide on the peripheral and central distribution and metabolism of levodopa after acute and chronic administration in the rat.
Kent AP; Stern GM; Webster RA
Br J Pharmacol; 1990 Aug; 100(4):743-8. PubMed ID: 2119841
[TBL] [Abstract][Full Text] [Related]
16. Interaction of catecholamine and amino acid metabolism in brain: effect of pargyline and L-dopa.
Nicklas WJ; Berl S; Clarke DD
J Neurochem; 1974 Jul; 23(1):149-57. PubMed ID: 4852502
[No Abstract] [Full Text] [Related]
17. The use of 3H-dopa for studying cerebral catecholamine metabolism.
Persson T; Waldeck B
Acta Pharmacol Toxicol (Copenh); 1968; 26(4):363-72. PubMed ID: 5755483
[No Abstract] [Full Text] [Related]
18. Evidence for an activating effect of tabernanthine on rat brain catecholamine synthesis and elimination.
Prioux-Guyonneau M; Mocaër-Cretet E; Cohen Y; Jacquot C
Experientia; 1984 Dec; 40(12):1388-9. PubMed ID: 6439570
[TBL] [Abstract][Full Text] [Related]
19. Regional effects of L-dihydroxyphenylalanine (L-dopa) on norepinephrine metabolism in rat brain.
Romero JA; Chalmers JP; Cottman K; Lytle LD; Wurtman RJ
J Pharmacol Exp Ther; 1972 Feb; 180(2):277-85. PubMed ID: 5010674
[No Abstract] [Full Text] [Related]
20. Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge.
Masana MI; Heyes MP; Mefford IN
Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):609-21. PubMed ID: 2236587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
